AlphaYouCR
Insider selling
Christopher Ryan Sullivan sold $202K of Avalo Therapeutics, Inc. (AVTX) stock
Christopher Ryan Sullivan, Chief Financial Officer of Avalo Therapeutics, Inc. (AVTX), sold 12,394 shares of AVTX stock worth $202K, per an SEC Form 4 filed Sep 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 16, 2026, 2 days before it was made public.
AVTX has moved -0.1% since the trade date, from $16.58 to $16.57 (Sep 18, 2026 close).
- Traded
- Sep 16, 2026
- Disclosed
- Sep 18, 2026
- Filing delay
- 2 days
- Price since
- -0.1%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More AVTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.